| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 9,225,000 | 12,923,000 | 12,981,000 | 13,624,000 | | Cost of Revenue | 7,027,000 | 10,066,000 | 9,704,000 | 10,036,000 | | | Gross Profit | 2,198,000 | 2,857,000 | 3,277,000 | 3,588,000 | | | Operating Expenses | | Research Development | 388,000 | 507,000 | 437,000 | 415,000 | | Selling General and Administrative | 1,706,000 | 413,000 | 1,376,000 | 1,369,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 104,000 | 1,937,000 | 1,464,000 | 1,804,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 64,000 | (1,207,000) | 138,000 | 75,000 | | Earnings Before Interest And Taxes | 168,000 | 730,000 | 1,602,000 | 1,879,000 | | Interest Expense | 380,000 | 370,000 | 350,000 | 349,000 | | Income Before Tax | (212,000) | 360,000 | 1,252,000 | 1,530,000 | | Income Tax Expense | (80,000) | (296,000) | 395,000 | 434,000 | | Minority Interest | 19,000 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (112,000) | 661,000 | 868,000 | 1,106,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (112,000) | 661,000 | 868,000 | 1,106,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($112,000) | $661,000 | $868,000 | $1,106,000 |
|
3.07% Nasdaq 
Income Statement
